Stockscreener 앱 받기
8.4117
5.36%
0.4317
전일 마감가:
$7.98
열려 있는:
$8.03
하루 거래량:
825.52K
Relative Volume:
0.40
시가총액:
$1.03B
수익:
-
순이익/손실:
$-29.07M
주가수익비율:
-29.01
EPS:
-0.29
순현금흐름:
$-31.85M
1주 성능:
-13.77%
1개월 성능:
+12.86%
6개월 성능:
+28.17%
1년 성능:
+146.56%
1일 변동 폭
$8.03
$8.46
1주일 범위
$7.645
$9.70
52주 변동 폭
$2.36
$9.92
트레비 테라퓨틱스 Stock (TRVI) Company Profile
명칭
Trevi Therapeutics Inc
전화
203-304-2499
주소
195 CHURCH STREET, NEW HAVEN, CT
TRVI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TRVI
Trevi Therapeutics Inc
|
8.42 | 971.78M | 0 | -29.07M | -31.85M | -0.29 |
|
VRTX
Vertex Pharmaceuticals Inc
|
385.53 | 99.26B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
597.54 | 62.06B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.71 | 59.21B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
730.50 | 44.94B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.69 | 36.57B | 3.81B | -644.79M | -669.77M | -6.24 |
트레비 테라퓨틱스 Stock (TRVI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-21 | 개시 | Morgan Stanley | Overweight |
| 2025-07-01 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-05-28 | 개시 | H.C. Wainwright | Buy |
| 2025-03-10 | 재확인 | Needham | Buy |
| 2025-03-10 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2024-12-12 | 재확인 | H.C. Wainwright | Buy |
| 2024-09-09 | 재개 | Leerink Partners | Outperform |
| 2024-08-30 | 개시 | H.C. Wainwright | Buy |
| 2024-08-30 | 개시 | Raymond James | Outperform |
| 2024-06-13 | 개시 | Rodman & Renshaw | Buy |
| 2023-04-12 | 개시 | B. Riley Securities | Buy |
| 2022-11-22 | 개시 | SVB Leerink | Outperform |
| 2019-06-03 | 개시 | BMO Capital Markets | Outperform |
| 2019-06-03 | 개시 | Needham | Buy |
| 2019-06-03 | 개시 | SVB Leerink | Outperform |
| 2019-06-03 | 개시 | Stifel | Buy |
모두보기
트레비 테라퓨틱스 주식(TRVI)의 최신 뉴스
Trevi Therapeutics to present two phase 2a River trial posters at ERS Congress 2025 - MarketScreener
Clinical Trial Results: Trevi's Breakthrough Chronic Cough Treatment Data to be Featured at European Congress - Stock Titan
Will Trevi Therapeutics Inc outperform its industry peers2025 Trading Recap & Long-Term Capital Growth Strategies - خودرو بانک
Trevi Therapeutics (NASDAQ:TRVI) Shares Down 4.6%Here's What Happened - MarketBeat
Siren L.L.C. Trims Holdings in Trevi Therapeutics, Inc. $TRVI - MarketBeat
Trevi Therapeutics (NASDAQ:TRVI) Sees Strong Trading VolumeWhat's Next? - MarketBeat
Fred Alger Management LLC Invests $482,000 in Trevi Therapeutics, Inc. $TRVI - MarketBeat
Gap Down: What is the PEG ratio of Trevi Therapeutics IncJuly 2025 Movers & AI Powered Trade Plan Recommendations - خودرو بانک
Dividend Watch: How much upside does Sintx Technologies Inc. haveMarket Rally & Risk Controlled Stock Pick Alerts - خودرو بانک
Revenue Check: How does Trevi Therapeutics Inc compare to its peersJuly 2025 Review & Risk Managed Investment Entry Signals - خودرو بانک
Risk Analysis: Will MSAI face regulatory challengesJuly 2025 Spike Watch & AI Driven Price Forecasts - خودرو بانک
Aug Volume: How does Trevi Therapeutics Inc compare to its peersQuarterly Trade Summary & Weekly Breakout Opportunity Watchlist - خودرو بانک
Woodline Partners LP Sells 1,154,785 Shares of Trevi Therapeutics, Inc. $TRVI - MarketBeat
Aug Wrap: Can Trevi Therapeutics Inc continue delivering strong returnsJuly 2025 Short Interest & Reliable Trade Execution Plans - خودرو بانک
Fund Flows: Will AVTX benefit from geopolitical trendsWeekly Trade Analysis & Breakout Confirmation Trade Signals - خودرو بانک
Trade Recap: Can Trevi Therapeutics Inc continue delivering strong returnsWeekly Stock Summary & Pattern Based Trade Signal System - خودرو بانک
US Market Wrap: Can Trevi Therapeutics Inc. keep up with sector leadersWeekly Trade Review & Daily Volume Surge Signals - خودرو بانک
Aug PreEarnings: Will Trevi Therapeutics Inc outperform its industry peersMarket Performance Summary & Entry Point Strategy Guides - خودرو بانک
Trevi Therapeutics (NASDAQ:TRVI) Hits New 1-Year HighTime to Buy? - MarketBeat
Acorn Capital Advisors LLC Has $13.49 Million Position in Trevi Therapeutics, Inc. $TRVI - MarketBeat
Octagon Capital Advisors LP Acquires Shares of 3,322,000 Trevi Therapeutics, Inc. $TRVI - MarketBeat
163,738 Shares in Trevi Therapeutics, Inc. $TRVI Purchased by Exome Asset Management LLC - MarketBeat
Brokerages Set Trevi Therapeutics, Inc. (NASDAQ:TRVI) PT at $21.75 - MarketBeat
Haduvio Opportunity Positions Trevi (TRVI) for Multibagger Gains, Says Morgan Stanley - MSN
Trevi Therapeutics (NASDAQ:TRVI) Stock Price Up 8.9%Should You Buy? - MarketBeat
Trevi Therapeutics, Inc. $TRVI Shares Sold by Adage Capital Partners GP L.L.C. - MarketBeat
Polar Asset Management Partners Inc. Purchases New Shares in Trevi Therapeutics, Inc. $TRVI - MarketBeat
Raymond James Financial Inc. Has $3.20 Million Stock Position in Trevi Therapeutics, Inc. $TRVI - MarketBeat
Cubist Systematic Strategies LLC Acquires 117,653 Shares of Trevi Therapeutics, Inc. $TRVI - MarketBeat
Trevi Therapeutics stock hits 52-week high at $8.80 - Investing.com
Trevi Therapeutics stock hits 52-week high at $8.80 By Investing.com - Investing.com Nigeria
Trevi Therapeutics at Morgan Stanley Conference: Strategic Focus on Cough Treatments - Investing.com Canada
Is Trevi Therapeutics Inc. stock poised for growthWeekly Investment Report & Growth Oriented Trading Recommendations - Newser
15 Best Multibagger Stocks to Invest in Right Now - Insider Monkey
Retail Trends: Is Trevi Therapeutics Inc. stock technically oversoldBull Run & Consistent Return Investment Signals - Lancaster City Council
What the charts say about Trevi Therapeutics Inc. today2025 Retail Activity & Technical Buy Zone Confirmations - Newser
What Fibonacci levels say about Trevi Therapeutics Inc. rebound2025 Institutional Moves & Free Weekly Chart Analysis and Trade Guides - Newser
Tools to assess Trevi Therapeutics Inc.’s risk profile2025 Volatility Report & Weekly Top Gainers Trade List - Newser
Trevi Therapeutics Inc. stock daily chart insightsPortfolio Growth Summary & Daily Growth Stock Tips - Newser
Visualizing Trevi Therapeutics Inc. stock with heatmapsMarket Activity Summary & Fast Moving Market Watchlists - Newser
Heatmap analysis for Trevi Therapeutics Inc. and competitors2025 Valuation Update & Weekly High Return Opportunities - Newser
Panagora Asset Management Inc. Purchases 219,600 Shares of Trevi Therapeutics, Inc. $TRVI - MarketBeat
Market reaction to Trevi Therapeutics Inc.’s recent newsJuly 2025 Pullbacks & Short-Term Swing Trade Alerts - Newser
Is Trevi Therapeutics Inc. stock ready for a breakoutMarket Movement Recap & Accurate Entry and Exit Point Alerts - Newser
Multi asset correlation models including Trevi Therapeutics Inc.Weekly Profit Recap & High Win Rate Trade Tips - Newser
트레비 테라퓨틱스 (TRVI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
트레비 테라퓨틱스 주식 (TRVI) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| SCIASCIA THOMAS | Chief Scientific Officer |
Mar 25 '25 |
Option Exercise |
1.43 |
2,631 |
3,762 |
224,004 |
| SCIASCIA THOMAS | Chief Scientific Officer |
Mar 25 '25 |
Sale |
6.60 |
2,631 |
17,365 |
221,373 |
| GOOD JENNIFER L | President & CEO |
Mar 21 '25 |
Option Exercise |
1.43 |
5,263 |
7,526 |
218,576 |
| GOOD JENNIFER L | President & CEO |
Mar 21 '25 |
Sale |
6.58 |
5,263 |
34,625 |
213,313 |
0.03%
0.92%
자본화:
|
볼륨(24시간):